| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |



From the Department of Pathology,*
Weill Medical College
of Cornell University, New York, New York; the Department of
Pathology,
Lenox Hill Hospital, New York, New
York; the Department of Pathology,||
College of Physicians
and Surgeons of Columbia University, New York, New York; the Delft
Diagnostic Laboratory,
Delft, the Netherlands;
the Department of Pathology,¶
Slotervaartziekenhuis, Amsterdam, The Netherlands; and the Laboratory
of Reproductive Pathomorphology,§
Warsaw
Medical School, Warsaw, Poland
The prevalence of human papilloma virus (HPV) DNA in different histological subtypes of cervical adenocarcinoma and related tumors was examined using formalin-fixed, paraffin-embedded tissue samples from 105 primary cervical adenocarcinomas and adenosquamous carcinomas. Broad-spectrum HPV DNA amplification and genotyping was performed with the SPF10 primer set and line probe assay (LiPA), respectively. HPV DNA was detected in 82 of 90 (91%) mucinous adenocarcinomas, encompassing endocervical, intestinal, and endometrioid histological subtypes, and in nine of nine adenosquamous tumors (100%). HPV DNA was not detected in any nonmucinous adenocarcinomas including clear cell, serous, and mesonephric carcinomas (0/6). The most common viral types detected in adenocarcinoma were HPV 16 (50%) and HPV 18 (40%), followed by HPV 45 (10%), HPV52 (2%), and HPV 35 (1%). Multiple HPV types were detected in 9.7% of the cases. In conclusion, mucinous adenocarcinomas and adenosquamous carcinomas of the cervix demonstrate a very high prevalence of HPV DNA, similar to that reported for cervical squamous cell carcinoma. Only rare histological variants of cervical adenocarcinoma seem unrelated to HPV infection.
This article has been cited by other articles:
![]() |
I. Kraus, T. Molden, R. Holm, A. K. Lie, F. Karlsen, G. B. Kristensen, and H. Skomedal Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas J. Clin. Microbiol., April 1, 2006; 44(4): 1310 - 1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Castellsague, M. Diaz, S. de Sanjose, N. Munoz, R. Herrero, S. Franceschi, R. W. Peeling, R. Ashley, J. S. Smith, P. J. F. Snijders, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst, March 1, 2006; 98(5): 303 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Castle, J. Jeronimo, M. Schiffman, R. Herrero, A. C. Rodriguez, M. C. Bratti, A. Hildesheim, S. Wacholder, L. R. Long, L. Neve, et al. Age-Related Changes of the Cervix Influence Human Papillomavirus Type Distribution Cancer Res., January 15, 2006; 66(2): 1218 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Burk, M. Terai, P. E. Gravitt, L. A. Brinton, R. J. Kurman, W. A. Barnes, M. D. Greenberg, O. C. Hadjimichael, L. Fu, L. McGowan, et al. Distribution of Human Papillomavirus Types 16 and 18 Variants in Squamous Cell Carcinomas and Adenocarcinomas of the Cervix Cancer Res., November 1, 2003; 63(21): 7215 - 7220. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dellas, J. Torhorst, R. Gaudenz, M. J. Mihatsch, and H. Moch DNA Copy Number Changes in Cervical Adenocarcinoma Clin. Cancer Res., August 1, 2003; 9(8): 2985 - 2991. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Walker, S. Kermorgant, E. Darai, P. Madelenat, A. C. Cremieux, D. Henin, and T. Lehy Hepatocyte Growth Factor and c-Met in Cervical Intraepithelial Neoplasia: Overexpression of Proteins Associated with Oncogenic Human Papillomavirus and Human Immunodeficiency Virus Clin. Cancer Res., January 1, 2003; 9(1): 273 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Powell, K. A. Bock, J. K. Gentry, W. C. White, and B. M. Ronnett Metastatic Endocervical Adenocarcinoma Presenting as a Virilizing Ovarian Mass During Pregnancy Obstet. Gynecol., November 1, 2002; 100(5): 1129 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Levi, B. Kleter, W. G. V. Quint, M. C. S. Fink, C. L. M. Canto, R. Matsubara, I. Linhares, A. Segurado, B. Vanderborght, J. E. Neto, et al. High Prevalence of Human Papillomavirus (HPV) Infections and High Frequency of Multiple HPV Genotypes in Human Immunodeficiency Virus-Infected Women in Brazil J. Clin. Microbiol., September 1, 2002; 40(9): 3341 - 3345. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Szuhai, E. Sandhaus, S. M. Kolkman-Uljee, M. Lemaitre, J.-C. Truffert, R. W. Dirks, H. J. Tanke, G. J. Fleuren, E. Schuuring, and A. K. Raap A Novel Strategy for Human Papillomavirus Detection and Genotyping with SybrGreen and Molecular Beacon Polymerase Chain Reaction Am. J. Pathol., November 1, 2001; 159(5): 1651 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Rubin, B. Kleter, M. Zhou, G. Ayala, A. L. Cubilla, W. G. V. Quint, and E. C. Pirog Detection and Typing of Human Papillomavirus DNA in Penile Carcinoma : Evidence for Multiple Independent Pathways of Penile Carcinogenesis Am. J. Pathol., October 1, 2001; 159(4): 1211 - 1218. [Abstract] [Full Text] |
||||
![]() |
T. Ohno, T. Nakano, A. Abe, T. Sano, Y. Niibe, and K. Oka Mucinous Adenocarcinoma of Bartholin Gland Treated with Radiation Therapy: a Case Report Jpn. J. Clin. Oncol., May 1, 2001; 31(5): 226 - 230. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |